Medical News

RSS

Phase I clinical trial of XRX-001 for yellow fever initiated

Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.

12 Jan 2010

Omnia Biologics and Biotech Experts announce deal for manufacturing and process development services

Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and biologics manufacturing and process development consultants Biotech Experts, Inc. (Clarksburg, MD) today announced a deal for manufacturing and process development services.

12 Jan 2010

Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial

Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel.

12 Jan 2010

Ibutilide Fumarate Injection launched

Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals announced today the launch of Ibutilide Fumarate Injection, the generic equivalent of Corvert® from Pfizer Inc.

12 Jan 2010

Life Technologies to acquire AcroMetrix

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.

12 Jan 2010

ALS TDI to receive grant of $1.6M for research and development of potential therapeutics for ALS

In recognition of multiple studies connecting ALS to military service, the 2010 Defense Appropriations Act, signed by President Obama on December 22, 2009, provided for the grant of $1.6 million for research and development of potential therapeutics for Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig's disease).

12 Jan 2010

Health bill negotiators consider applying Medicare tax to investment income, WSJ reports

News outlets explore some of the unsettled and sticky policy questions - such as what taxes might pay for it, and whether mandates to buy coverage should be included - in the health overhaul legislation.

12 Jan 2010

White House considers help with proposed Medicaid expansion for states

Reuters: "President Barack Obama is discussing ways to help U.S. states cover costs that are destined to rise under pending healthcare reform legislation, his press secretary said on Monday." A number of governors have "protested a special funding allocation for Nebraska in the bill. 'We're

12 Jan 2010

3D structure of PI3Kdelta: An important drug target for a wide range of diseases

Intellikine announced today the publication of an article entitled, "The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors," now available as an advanced online publication at Nature Chemical Biology.

12 Jan 2010

ARKRAY's Assure Platinum Blood Glucose Monitoring System launched in the U.S.

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, has officially launched the new Assure Platinum Blood Glucose Monitoring System.

12 Jan 2010

Older patients with acute myeloid leukemia may benefit from decitabine drug

Older patients with acute myeloid leukemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating institutions.

12 Jan 2010

ANI launches professional development program that pairs nurses with mentors

Two nurses have won recognition as emerging leaders in the field of nursing informatics, selected by the Alliance for Nursing Informatics (ANI) to participate in a jointly supported Nursing Informatics Emerging Leaders Program.

12 Jan 2010

Increased doses of erlotinib drug may lead to better outcomes in lung cancer patients

Although erlotinib is an approved second-line therapy for lung cancer, its management is complicated by side effects that get worse as the dose increases.

12 Jan 2010

Evidence-based care for lung cancer patients results in an average cost savings of 35%, says study

A study recently conducted by US Oncology and Aetna finds that evidence-based care for patients with non-small cell lung cancer (NSCLC) results in an average cost savings of 35 percent over 12 months while demonstrating equivalent health outcomes. The study, which compared patients treated with evidence-based guidelines (also known as ‘on pathway’) to those treated with non-evidence-based guidelines (also known as ‘off pathway’), was published in the peer-reviewed Journal of Oncology Practice.

12 Jan 2010

Richard N. Zare to receive the 2010 TWR Medal for Conspicuous Achievement in Chemistry

Richard N. Zare, the Marguerite Blake Wilbur Professor in Natural Science at Stanford University has been selected to receive the 2010 Theodore William Richards (TWR) Medal for Conspicuous Achievement in Chemistry from the Northeastern Section of the American Chemical Society (NESACS).

12 Jan 2010

Alleged sex offender not a registered physiotherapist, confirms the College of Physiotherapists of Ontario

The College of Physiotherapists of Ontario, the organization entrusted by government and the public to regulate the over 7,000 physiotherapists in the province, was distressed to hear of the alleged abuse of a 15 year old female by an individual claiming to provide physiotherapy services. The College clarifies for the public that Sedat Ozdemir is not a registered physiotherapist in Ontario.

12 Jan 2010

First Edition: January 12, 2010

Today's news coverage details developments related to pending health reform plans with President Obama's meeting with organized labor regarding the 'Cadillac' tax claiming a lot of headlines.

12 Jan 2010

CBIZ acquires National Benefit Alliance

CBIZ, Inc. today announced the acquisition of National Benefit Alliance ("NBA"), an employee benefits firm located in Midvale, Utah, effective January 1, 2010.

12 Jan 2010

miRagen Therapeutics establishes SAB

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company’s world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.

12 Jan 2010

Medtech Investment Week to be held in Stockholm

On February 10-12th 2010, Medtech Investment Week is being held in Stockholm. The program features a tour of the Stockholm-Uppsala life science sector, providing a unique, exclusive and efficient opportunity to cover the latest news from one of the world’s leading medtech clusters.

12 Jan 2010

Medical News

Phase I clinical trial of XRX-001 for yellow fever initiated

Omnia Biologics and Biotech Experts announce deal for manufacturing and process development services

Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial

Ibutilide Fumarate Injection launched

Life Technologies to acquire AcroMetrix

ALS TDI to receive grant of $1.6M for research and development of potential therapeutics for ALS

Health bill negotiators consider applying Medicare tax to investment income, WSJ reports

White House considers help with proposed Medicaid expansion for states

3D structure of PI3Kdelta: An important drug target for a wide range of diseases

ARKRAY's Assure Platinum Blood Glucose Monitoring System launched in the U.S.

Older patients with acute myeloid leukemia may benefit from decitabine drug

ANI launches professional development program that pairs nurses with mentors

Increased doses of erlotinib drug may lead to better outcomes in lung cancer patients

Evidence-based care for lung cancer patients results in an average cost savings of 35%, says study

Richard N. Zare to receive the 2010 TWR Medal for Conspicuous Achievement in Chemistry

Alleged sex offender not a registered physiotherapist, confirms the College of Physiotherapists of Ontario

First Edition: January 12, 2010

CBIZ acquires National Benefit Alliance

miRagen Therapeutics establishes SAB

Medtech Investment Week to be held in Stockholm

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News